SE384021B - Sett att framstella racemisk och optiskt aktiv 1-(2,5-diklorfenoxi)-3-tert.-butylamino-2-propanol och salter derav - Google Patents

Sett att framstella racemisk och optiskt aktiv 1-(2,5-diklorfenoxi)-3-tert.-butylamino-2-propanol och salter derav

Info

Publication number
SE384021B
SE384021B SE7203354A SE335472A SE384021B SE 384021 B SE384021 B SE 384021B SE 7203354 A SE7203354 A SE 7203354A SE 335472 A SE335472 A SE 335472A SE 384021 B SE384021 B SE 384021B
Authority
SE
Sweden
Prior art keywords
dichlorophenoxy
butylamino
racemic
propanol
tert
Prior art date
Application number
SE7203354A
Other languages
English (en)
Swedish (sv)
Inventor
A Hajos
M Fekete
M Kurti
S Elek
I Polgari
I Elekes
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Publication of SE384021B publication Critical patent/SE384021B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/12Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/28Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines
    • C07C217/30Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring
    • C07C217/32Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
    • C07C217/34Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted by halogen atoms, by trihalomethyl, nitro or nitroso groups, or by singly-bound oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Epoxy Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE7203354A 1971-03-17 1972-03-15 Sett att framstella racemisk och optiskt aktiv 1-(2,5-diklorfenoxi)-3-tert.-butylamino-2-propanol och salter derav SE384021B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HUGO001156 1971-03-17

Publications (1)

Publication Number Publication Date
SE384021B true SE384021B (sv) 1976-04-12

Family

ID=10996691

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7203354A SE384021B (sv) 1971-03-17 1972-03-15 Sett att framstella racemisk och optiskt aktiv 1-(2,5-diklorfenoxi)-3-tert.-butylamino-2-propanol och salter derav

Country Status (19)

Country Link
JP (1) JPS5310581B1 (cs)
AT (1) AT316515B (cs)
AU (1) AU461159B2 (cs)
BE (1) BE780719A (cs)
CA (1) CA1002537A (cs)
CH (1) CH569692A5 (cs)
CS (1) CS163270B2 (cs)
DK (1) DK133872B (cs)
ES (1) ES401235A1 (cs)
FI (1) FI55025C (cs)
FR (1) FR2130284B1 (cs)
GB (1) GB1337921A (cs)
IL (1) IL38870A (cs)
NL (1) NL170626C (cs)
NO (1) NO134836C (cs)
PL (1) PL88985B1 (cs)
SE (1) SE384021B (cs)
SU (1) SU496721A3 (cs)
YU (1) YU35435B (cs)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU172137B (hu) 1976-03-02 1978-06-28 Gyogyszerkutato Intezet Sposob poluchenija zamehhjonnykh proizvodnykh fenoksi-propanolamina

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1236523C2 (de) * 1962-02-15 1975-06-12 Sanol-Arzneimittel Dr. Schwarz Gmbh, 4019 Monheim Verfahren zur herstellung von basischen phenylaethern und deren salzen

Also Published As

Publication number Publication date
AT316515B (de) 1974-07-10
AU3965972A (en) 1973-09-13
NL170626B (nl) 1982-07-01
FI55025C (fi) 1979-05-10
GB1337921A (en) 1973-11-21
ES401235A1 (es) 1975-02-16
AU461159B2 (en) 1975-04-29
DE2213044B2 (de) 1977-05-26
DK133872B (da) 1976-08-02
CA1002537A (en) 1976-12-28
CH569692A5 (cs) 1975-11-28
PL88985B1 (cs) 1976-10-30
NL170626C (nl) 1982-12-01
SU496721A3 (ru) 1975-12-25
JPS5310581B1 (cs) 1978-04-14
FR2130284B1 (cs) 1975-10-10
YU63972A (en) 1980-06-30
YU35435B (en) 1981-02-28
FI55025B (fi) 1979-01-31
NL7203323A (cs) 1972-09-19
DE2213044A1 (de) 1972-09-28
NO134836C (cs) 1976-12-21
BE780719A (fr) 1972-07-03
NO134836B (cs) 1976-09-13
IL38870A0 (en) 1972-05-30
FR2130284A1 (cs) 1972-11-03
CS163270B2 (cs) 1975-08-29
IL38870A (en) 1975-08-31
DK133872C (cs) 1976-12-27

Similar Documents

Publication Publication Date Title
SE407799B (sv) Sett att framstella racemiska och optiskt aktiva 4-(polyalkoxifenyl)-2-pyrrolidoner anvendbara som nevropsykotropa lekemedel
ATA661577A (de) Verfahren zur herstellung von neuen, optisch akti-ven 3-azabicyclo(3.1.0)hexanderivaten und ihren nichttoxischen, pharmazeutisch vertraeglichen salzen
NO149999C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme n-(4-acyloksyfenyl)-all-trans-retinamider.
SU437293A3 (ru) Способ получения рацемических или оптически активных производных пиперазина
SE405970B (sv) Nytt sett att framstella 2-arylamino-2-imidazolin-derivat och salter derav
SE390171B (sv) Sett att framstella 7-(d-alfa-amino-alfa-fenylacetamido)-3-(s-(5-hydroaximetyl-1,3,4-oxadiazol-2-yl)tiometyl)-3-cefem-4-karbonsyra och icke toxiska, farmaceutiskt acceptabla salter derav
SE399560B (sv) Sett att framstella salter av oŸ2,2'-anhydro-1-(3'-o-acyl-5'-o-acylbeta-d-arabinofuranosyl)-cytosiner
SE384021B (sv) Sett att framstella racemisk och optiskt aktiv 1-(2,5-diklorfenoxi)-3-tert.-butylamino-2-propanol och salter derav
SE414768B (sv) Forfarande for framstellning av alfa-aminobensylpenicilliner och salter derav
SE388857B (sv) Sett att framstella 3-(4-oxo-4h-1-bensopyran-3)-akrylsyrade-rivat
SE387940B (sv) Forfarande for framstellning av stereoisomerer av 1-(1-(-kloorbensyl)-2'-pyrryl)-2-disek, butylaminoetanol
SU437289A1 (ru) Способ получени рацемических или оптически активных производных пиперазина
SE7508827L (sv) Forfarande och anordning for skakning av den ovre lopande parten i en planviramaskin.
SE401829B (sv) Forfarande for framstellning av 5-fenyl-6,7-bensomorfanderivat och salter derav
SU558638A3 (ru) Способ получени соединений 1-фенокси-2-окси-3-аминопропана или их солей в виде рацемата или оптическиактивного антипода
SE384863B (sv) Forfarande for framstellning av 3,6-bis- (2-(1-azabicyklo(3,1,0)-hexan))-2,5-piperazindion
SE411672B (sv) Forfarande for framstellning av 1-(metylerad piperidino (och pyrrolidin-1-yl))-3-(substituerad fenoxi)-2-propanoler med terapeutisk verkan
SE7603779L (sv) Forfarande for framstellning av c-(2,6-dikloroanilino)fenylettiksyra och salter derav
SE7613536L (sv) Sett att framstella 3,4-disubstituerade 2-(beta-naftyl-oxi)-etylpyrazoloner och anvendning derav som lekemedel
NO145436C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aminer.
NO145274C (no) Fremgangsmaate for fremstilling av et 1-benzoyl-2-(2`,6`-diklorfenylamino)-2-imidazolin og av deres salter
SE412830B (sv) Forfarande for ljuduppteckning i och for stereoatergivning, samt anordning i och for genomforande av forfarandet
FI54409B (fi) Anordning foer uppvaermning av en vaetskesuspension med en annan vaetskesuspension
SE399887B (sv) Forfarande for framstellning av optiskt aktiva 1,4-bensodiazepinforeningar
SE388607B (sv) Forfarande for framstellning av en tioalkylamin och salter derav